Introduction 76
Influenza viruses are the cause of significant morbidity and mortality worldwide with 77 seasonal epidemics causing between 250,000 and 500,000 annual fatalities. Therefore 78 continued effort is required to understand influenza virus biology for development of 79 improved antiviral drugs and vaccines. Much of this effort is focused on studying influenza 80
A viruses due to their ability to cause worldwide pandemics (1). However, although 81 influenza B viruses are strictly human pathogens and as such do not have the potential to 82 create such pandemic strains, they are responsible for significant seasonal epidemics (1). 83
In fact influenza B viruses are the predominant circulating strain of influenza virus in one 84 of every three years (2), making these viruses no less significant than their influenza A 85 virus counterparts. 
Materials and Methods 151

Cell and Viruses 152
293T and MDCK cells were maintained in Dulbecco's modified Eagle's medium (DMEM) 153 (Invitrogen) supplemented with 10% fetal calf serum (FCS) at 37 °C with 5% CO 2 . 154 B/Yamanashi/98 wild-type (rBNP wt) and mutant viruses were generated using plasmid-155 based reverse genetics as previously described (4, 5). Briefly, 293T cells were transfected 156 with eight genome-encoding bi-directional (pAB) plasmids using FuGENE 6 transfection 157 reagent (Promega) and at 16 h post-transfection the cells were co-cultured with MDCK 158 cells in serum-free DMEM containing 2.5 μg/mL N-acetyl trypsin (Sigma). Virus-containing 159 supernatant was harvested 4 days post-transfection, viruses propagated twice through 160 MDCK cells followed by plaque assay titration on MDCK cells. Viral RNA was extracted 161 using the QIAamp viral RNA kit (QIAGEN), followed by reverse-transcriptase PCR using 162 genome specific primers and the resultant DNA sequenced to confirm presence of the 163 desired mutations. 164
165
Plasmids 166
For protein expression experiments the B/Yamanashi/98 NP ORF was inserted into the 167 pCAGGS mammalian expression vector and an HA tag was fused to the C-terminus. 168
Mutations were introduced by site directed mutagenesis (primer sequences available on 169 request) and the presence of the desired mutations confirmed by DNA sequencing. For 170 virus recovery the pAB-NP plasmid was mutated by site-directed mutagenesis and 171 substituted into the reverse genetics system. To create the pHH-BNSren reporter plasmid 172 PCR primers were designed to amplify the renilla luciferase gene flanked by the non-173 coding regions of the NS segment of the B/Yamanashi/98 virus (primer sequences 174 available on request). The resultant PCR product was cloned into the pHH-21 reverse-175 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from genetics plasmid between the human RNA polymerase I promoter and terminator regions 176 using BsmBI restriction sites. 177
Immunofluorescence 225 293T cells were transfected with 100 ng of the pCAGGS-NP constructs for 24 hours 226 followed by fixation in 5% formaldehyde and permeabilization in PBS/0.5% Triton X-227 100/0.5% NP40. Cells were blocked in PBN blocking buffer (PBS/1% BSA/0.02% sodium 228 azide) for 1 h at room temperature followed by incubation with either an anti-influenza B 229 NP monoclonal antibody (Abcam) or a rabbit polyclonal anti-HA antibody (Sigma). Cells 230 were then incubated with either a Texas Red-conjugated goat anti-mouse (Abcam) or 231
Alexa Fluor 488-conjugated goat anti-rabbit secondary antibody (Life Technologies), 232 followed by incubation with 1 μg/ml 4',6-diamidino-2-phenylindole (DAPI) for 5 min. 233
Images were captured at either 20x or 63x magnification using an Axioplan 2 epi-234 fluorescent microscope (Zeiss), data analyzed using Axiovision 4. 
Plaque assays 250
MDCK cells in six-well plates were infected with serial 10-fold dilutions of each virus in 251 serum-free DMEM for 1 h at 37 °C. Cells were overlaid with DMEM-1% agarose 252 supplemented with 2 μg/ml N-acetyl trypsin and incubated at 37 °C for 72 h. Cells were 253 fixed in 5% formaldehyde and plaques visualized by staining with 1% crystal violet. 254
255
Quantitative reverse transcription-PCR (qRT-PCR) 256
Renilla mRNA, vRNA and cRNA were quantified in samples used in the luciferase-based 257 mini-replicon assay by qRT-PCR. Total cellular RNA was extracted from transfected 293T 258 cells using the RNeasy Kit (QIAGEN). Total mRNA was reverse transcribed using an 259
Oligo(dT) primer (Promega) and renilla vRNA or cRNA was reverse transcribed using 260 renilla vRNA or cRNA gene-specific primers, using RevertAid Premium Reverse 261
Transcriptase (Thermo Scientific). For qPCR renilla gene-specific primers (sequences 262 available on request) were designed to amplify a 150 nt fragment of DNA and various 263 concentrations of primers were optimised against each other by qPCR using various 264 concentrations of pHH-BNSren as a standardized template. cDNAs generated by reverse 265 transcription were then assayed by qPCR using serial four-fold dilutions of cDNA and 266 1μM renilla gene-specific primers using Precision Mastermix (Primer Design) on a 267
Stratagene Mx3005P real-time PCR thermocycler. A standard curve was generated using 268 serial 10-fold dilutions of pHH-BNSren and used to convert ct values of cDNA samples 269 into DNA concentrations. The cDNA samples were also analysed for actin mRNA content 270 using actin gene-specific primers to normalize for cell number. cDNA samples were then 271 also analysed for firefly luciferase (FFluc) mRNA content using FFluc gene-specific 272 primers to normalize for transfection efficiency. After renilla cDNA values were normalised 273 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from for cell number and transfection efficiency the data was expressed as a percentage of the 274 BNP wt transfected cells. All results show the average of triplicate qPCR analyses ± SD. 275
276
For quantification of viral mRNA, vRNA and cRNA levels MDCK cells were infected with 277 rBNP wt or mutant viruses at an MOI of 5 and at various times post-infection total cellular 278 mRNA was extracted using the RNeasy kit. Total mRNA was reverse transcribed using an 279
Oligo(dT) primer and viral vRNA/cRNA (HA gene segment) was reverse transcribed using 280 either an HA vRNA or HA cRNA gene-specific primer, using RevertAid Premium Reverse 281
Transcriptase. For qPCR HA gene-specific primers (sequences available on request) 282 were designed to amplify a 150 nt fragment of DNA, primers were optimised and used in 283 qPCR as above using serial four-fold dilutions of cDNA and pAB-HA plasmid as a DNA 284 standard. The cDNA samples were also analysed for actin mRNA content using actin 285 gene-specific primers to normalize for cell number. After actin normalization the data was 286 
Results
299
The influenza B virus NP N-terminal extension is required for optimal replication of 300 a viral-like RNA. 301
To determine whether the N-terminal extension of the influenza B virus NP (BNP) is 302 required for optimal viral replication constructs were created that expressed serially 303 truncated versions of BNP (Fig. 1A) . The BNP ORF was inserted into the pCAGGS 304 mammalian expression plasmid and the ATG initiation codons at positions one and four 305 were removed by site-directed mutagenesis to create the pCAGGS-BNP-ΔATG plasmid. 306 ATG initiation codons were then introduced into the BNP ORF at codon positions 11, 21, 307 31, 41 and 51 and an HA tag was introduced at the 3' end of the ORF. We also identified 308 residues K44 and R45 as part of a putative nuclear localization signal (NLS), which has 309 since been reported by Wanitchang et al., (2013) . Therefore the pCAGGS-BNP-310 K44A/R45A construct was created in which residues 44 and 45 were mutated to alanine 311 (Fig. 1A) . The panel of mutant constructs were then used in a mini-replicon assay to 312 assess the ability of the mutant BNP proteins to support replication of a viral-like RNA. For 313 this purpose a mini-replicon plasmid (pHH-BNSren) was created in which the renilla 314 luciferase gene was inserted between the non-coding regions of the influenza B virus 315 vRNA segment eight and inserted into a plasmid in a negative sense orientation under the 316 control of the human RNA polymerase I promoter. The pHH-BNSren plasmid was 317 transfected into 293-T cells alongside plasmids expressing the viral polymerase subunits 318 and the panel of BNP mutants and 24 hours post-transfection (h.p.t.) the luciferase 319 activity was measured. Despite residues 44 and 45 appearing to be part of a NLS, 320 mutation of these residues did not significantly affect the ability of BNP to support 321 replication of a viral-like RNA as luciferase levels were similar to those of wild-type (wt) 322 BNP (Fig. 1B) . However as the 50 amino acid extension was serially truncated by 10 323 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from amino acids at a time the luciferase activity was successively reduced such that complete 324 removal of the first 50 residues of BNP (BNP-P51M) resulted in less than 40% luciferase 325 activity when compared to wt BNP. This reduction was not due to lower expression or 326 instability of the truncated BNP proteins as expression levels were similar for each 327 construct (Fig. 1C) . 328
329
It was noted that a protein product with a lower molecular weight than wt BNP was 330 expressed by the pCAGGS-BNP-ΔATG plasmid ( Fig. 1C and D) . In this construct the first 331 ATG the ribosome would encounter is at codon 82 and is in frame with the BNP ORF. 332
This protein product (hereafter termed BNP-Δ81) would be 479 amino acids in size with 333 an approximate molecular weight of 48-50 kDa and is likely the protein product observed 334 in Fig. 1C . As the BNP-Δ81 protein lacks the epitope for the BNP-specific antibody the 335 protein could only be detected using the anti-HA antibody. Immunofluorescence analysis 336
suggests that this protein is virtually entirely cytoplasmic (Fig. 1D) , thereby confirming that 337 the N-terminal extension is essential for nuclear localization of BNP. Nuclear localization 338 was analysed for all of the mutant BNP proteins by immunofluorescence using a BNP-339 specific antibody. Increasing truncation appeared to increase the number of cells that 340 contained predominant cytoplasmic localization ( Fig. 2A ). For each mutant nuclear versus 341 cytoplasmic localization was determined by cellular fractionation and immunoblotting (Fig.  342   2B) . The BNP-K44A/R45A mutation resulted in an increase in the cytoplasmic localization 343 of BNP compared to BNP wt (Fig. 2C) . If residues 44 and 45 are part of an NLS their 344 removal must be compensated for by another region of the N-terminal extension. 345
Furthermore the luciferase data ( displayed vRNA and cRNA levels higher than those of the "no polymerase" negative 362 control suggesting all mutants were able to aid in replication of vRNA, albeit to a lower 363 level than BNP wt. The vRNA levels in the "no polymerase" control demonstrate the levels 364 of vRNA driven from the pHH-BNSren plasmid only as the cRNA levels for this mutant 365 suggest that no vRNA replication took place. The vRNA levels in the BNP-ΔATG sample 366
were increased compared to the negative control and the cRNA levels suggest that this 367 was due to a very low level of vRNA replication. Therefore despite the complete inactivity 368 of the BNP-ΔATG mutant in the luciferase activity assay (due to the lack of mRNA 369 synthesis) the BNP-Δ81 protein produced from this mutant construct was able to aid 370 replication of vRNA, suggesting that the transcriptase activity of the polymerase was more 371 significantly affected by the removal of the 81 N-terminal residues of BNP than its genome 372 replicative ability. 373 on July 13, 2017 by guest http://jvi.asm.org/
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In this assay system newly synthesized vRNA is able to act as a template for the 375 production of mRNA, therefore decreases in vRNA synthesis should lead to decreases in 376 mRNA levels. It is therefore possible that the reductions in renilla protein production were 377 due not only to reductions in BNP nuclear localization but also to reductions in the levels 378 of vRNA produced as a consequence of the BNP mutations. and resulted in production of another protein product of a lower molecular weight (Fig.  393 4B). It is likely that these mutant forms of BNP are less stable and that the observed 394 protein product is a cleaved form of BNP, as similar findings were reported by Wanitchang 395
When the mutant constructs were used in the luciferase-based mini-replicon reporter 398 assay all mutant BNP proteins displayed a reduced ability to support replication of a viral-399 like RNA, with only the BNP-M4 and BNP-D7E mutants reaching 80% luciferase activity 400 when compared to wt BNP (Fig. 4C) . The greatest reduction in luciferase activity was 401 observed for the BNP-D5M mutant. It is possible that this may be due to the lower 402 The panel of mutants was tested for cellular distribution of BNP. Mutants BNP-D7M, BNP-412 G8M, BNP-N10M and BNP-D7A displayed moderate increases in cytoplasmic localization 413 compared to wt BNP, with increasing truncation leading to slight increases in cytoplasmic 414 localization (Fig. 5A) . The BNP-I6M mutant was the only BNP protein to show a 415 considerable increase in cytoplasmic localization. The reason for this is unclear, however 416 both the reduction in nuclear availability of this mutant and the decrease in protein levels 417 likely resulted in the decrease in luciferase levels observed in Fig. 4C . The BNP-D5M 418 mutant actually demonstrated a slightly enhanced nuclear localization when compared to 419 BNP wt (Fig. 5A ). Although this was not a considerable enhancement it demonstrates that 420 the reduction in luciferase activity for the BNP-D5M mutant was likely not due to an 421 alteration in cellular distribution of BNP. Therefore the most likely explanation for the 422 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from reduction in BNP-D5M-mediated luciferase levels was due to the mutation affecting an 423 essential function of BNP during mRNA transcription/replication. To address this the 424 levels of renilla mRNA, vRNA and cRNA in the mini-replicon samples (Fig. 4C) were 425 assessed by qRT-PCR. As expected renilla mRNA levels mirrored the levels of luciferase 426 activity in Fig 4C (data not shown) , however differences were observed in renilla vRNA 427 and cRNA levels (Fig. 5B) . All mutant BNP proteins with the exception of BNP-D7E 428 displayed reduced levels of renilla vRNA of between 55 and 80% that of BNP wt. This 429 suggests that individual amino acid truncations in the first ten residues of BNP reduce the 430 ability of BNP to aid in replication of a viral-like RNA and this region of BNP is essential 431 for optimal genome replication. Interestingly, despite displaying the highest luciferase 432 activity of any of the mutants the BNP-M4 mutant displayed a similar reduction in vRNA to 433 the other truncation mutants. The reason for this is unclear, however it is plausible that 434 the ability of the BNP-M4 protein to aid transcription of mRNA is affected to a lesser 435 extent than the other mutants, which would result in higher levels of BNP-M4 mRNA 436 compared to the other mutants, despite similar levels of vRNA production. 437
438
The mutations were then introduced into the pAB-NP plasmid for virus recovery. Only the 439 BNP-M4 and BNP-D7E mutations allowed recovery of viruses, suggesting that BNP can 440 only withstand the truncation of 3 residues without compromising virus viability. 441
Interestingly these were the only two mutant proteins able to support luciferase activity 442 levels to over 80% of BNP wt, with other mutants showing reduced luciferase activity (Fig.  443   4C) . These results suggest that the composition of residues in this region of BNP is 444 essential for virus viability. and titrated by plaque assay. All three mutant viruses were attenuated compared to wt 452 virus and reached their peak titer 12-24 hours after that of rBNP wt virus (Fig. 6A) . 453
Although the rBNP-K44A/R45A virus was attenuated 10-fold at early time points it 454 reached a similar titer to rBNP wt. However the rBNP-M4 and rBNP-D7E mutants showed 455 greater attenuation, especially at early time points, therefore it was plausible that the 456 effects of the mutations were more prominent during the first few rounds of replication. (Fig. 7B ) and cellular 486 fractionation (Fig. 7C) . Cellular distribution of BNP in rBNP-M4 and rBNP-D7E virus-487 infected cells was not significantly different to that in rBNP wt virus-infected cells at each 488 time point (Fig. 7B and C) . However at all times post-infection rBNP-K44A/R45A virus-489 infected cells displayed significant increases in cytoplasmic BNP localization (Fig. 7C) , 490 confirming the notion that these residues form part of a NLS. This may also indicate that 491 the slight reduction in luciferase levels observed for the rBNP-K44A/R45A mutant in Fig.  492 7A were due to a decrease in the levels of nuclear BNP compared to those in rBNP wt 493 virus-infected cells. However as there were no significant differences in cellular BNP 494 distribution for the rBNP-M4 and rBNP-D7E mutants compared to rBNP wt the reduction 495 The effects of the mutations on the ability of BNP to participate in both transcription of 501 viral mRNA and genome replication were assessed. MDCK cells were infected with each 502 virus at an MOI of 5 and at various times post-infection total cellular RNA was extracted 503
for qRT-PCR analysis using primers specific for viral mRNA, vRNA and cRNA. At 4 h.p.i 504 viral mRNA was reduced in all mutant virus-infected cells compared to rBNP wt virus-505 infected cells (Fig. 8A) . By 8 h.p.i. mRNA levels in the rBNP-K44A/R45A mutant virus-506 infected cells were actually higher than in rBNP wt virus-infected cells, whereas the other 507 mutants demonstrated significantly decreased levels of mRNA. Levels of mRNA in the 508 rBNP-D7E virus-infected cells increased between 4 and 6 h.p.i., however this began to 509 decrease and by 8 h.p.i. mRNA levels were back to those observed at 4 h.p.i., 510 approximately 40% of rBNP wt mRNA. The mRNA levels in rBNP-M4 virus-infected cells 511 remained at 40-50% those of rBNP wt throughout the experiment. These decreases in 512 mRNA levels were likely responsible for the attenuation in the growth curves (Fig. 6) and 513 the reduction in luciferase levels (Fig. 7A) . The reduction in rBNP-K44A/R45A mRNA 514 levels at early time points suggests that this mutant exhibits a delay in mRNA synthesis, 515 which is likely responsible for the slight reduction in luciferase levels in Fig. 7 , however as 516 wt-like levels of mRNA are produced within the time frame of a single cycle of replication 517 this explains the lack of attenuation of the mutant in the growth curve. 
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To determine whether the observed reduction in mRNA levels was a result of altered 520 vRNA or cRNA levels produced during infection the samples were also analysed for 521 vRNA/cRNA content by qRT-PCR. Interestingly the rBNP-K44A/R45A mutant 522 demonstrated increased vRNA and cRNA levels at all time points when compared to 523 rBNP wt (Fig. 8B and 8C) , despite the reduction in mRNA levels at early time points. This 524 may suggest that this mutant BNP protein exhibits a preference for genome replication 525 over transcription, as it is not until vRNA levels reach 200% those of rBNP wt that the 526 rBNP-K44A/R45A mRNA levels reach those of rBNP wt virus-infected cells. Both the 527 rBNP-M4 and rBNP-D7E virus-infected cells contained strikingly reduced vRNA/cRNA 528 levels when compared to rBNP wt, with the trend in vRNA/cRNA levels over time 529 mirroring the mRNA levels in Fig. 8A . These results suggest that the mutations in the first 530 ten residues of BNP significantly reduce the ability of the protein not only to function in 531 mRNA transcription but also vRNA replication, which likely has a subsequent affect on 532 However as no nucleotides were deleted from the BNP ORF in our experiments and only 562 minimal nucleotide changes were made it is unlikely that the lack of virus recovery was 563 due to defects in packaging signals. 564
565
Increasing the length of BNP truncation increased the extent of cytoplasmic localization of 566 the protein, which correlated with a reduction in the ability of the mutant BNP proteins to 567 support replication of a mini-genome reporter (Fig. 1B) . This suggests that the truncated 568 proteins were still able to function in transcription/replication if the protein was able to 569 Even though all AUG initiation codons within the N-terminal extension of the BNP-ΔATG 582 mutant were removed, a protein product (BNP-Δ81) was observed (Fig. 1) , which is likely 583 due to translational read-through. As the BNP-P51M mutant resulted in some nuclear 584 localization of BNP but the BNP-Δ81 protein was virtually entirely cytoplasmic (Fig. 1D ) 585 this indicates that all NLS sequences in BNP are within the first 81 residues and that a 586 region of BNP between residues 51 and 81 must contribute to nuclear localisation. We 587 also noted that a particular sequence in BNP (K 44 RTR 47 ) resembled an NLS, an 588 observation that has since been reported to be functional by another group (Wanitchang, 589 2013) . When this potential NLS was removed (BNP-K44A/R45A) cytoplasmic 590 accumulation of BNP increased (Fig. 2B) . Although Wanitchang et al. report 
that in the 591
context of a full-length BNP protein this mutant was exclusively cytoplasmic our results 592 suggest otherwise as 53% of mutant BNP protein was detected in the nuclear fraction of 593 BNP-K44A/R45A transfected cells. Therefore although this sequence is involved it is not 594 25 essential for nuclear localization of BNP as i) this mutant was able to support 595 transcription/replication of a mini-replicon to similar levels to those of wt BNP (Fig. 1B) ; 596
and ii) a mutant virus bearing these mutations was viable. Wanitchang et al. indicated that 597 two regions of the BNP appear to be required for nuclear localization, residues 3-15 and 598 44/45. Despite our BNP-P51M mutant lacking both of these regions, 33% of BNP-P51M 599 protein was found in the nuclear fraction (Fig. 2C ). Taken together with the fact that the 600 BNP-Δ81 protein was virtually entirely cytoplasmic this strengthens the hypothesis that 601 residues between positions 51 and 81 also participate in nuclear localization of BNP. It is 602 possible that residues 44/45 and others between 51 and 81 form a bipartite NLS. Overall 603 our results confirm that the N-terminal extension of BNP is essential for its nuclear import, 604 that multiple regions of this extension are involved and that the N-terminal region in its 605 entirety is required for BNP to function optimally in this capacity. 606
607
Reductions in nuclear localization of the N-terminally truncated BNP proteins was likely 608 partially responsible for the lack of virus recovery, however our results also demonstrate 609 that the effects of the truncations on the ability of BNP to aid in transcription and 610 replication of vRNA likely contributed to the failure to recover infectious virus. Although 611 the BNP-Δ81 protein was able to allow a low level of vRNA replication to occur it was 612 completely unable to aid in mRNA transcription. This possibly indicates that there are 613 separate mechanisms behind the roles of BNP in mRNA transcription and viral genome 614 replication and that the BNP N-terminus, although required for optimal levels of both, is 615 absolutely essential for viral mRNA transcription to occur. Further work is required to 616 dissect these mechanisms to understand the functional roles of BNP in these processes. (Fig. 4B) . However as this band is such a minor species or completely absent from 624 most of the mutants it is unlikely that the lack of virus recovery was due to the truncations 625 preventing BNP from inhibiting its own cleavage. Despite this, both this study and that of 626 thought that this cleavage mechanism is involved in regulating apoptosis during viral 636 infection. Therefore we sought to test whether this sequence in BNP is required for virus 637 viability. For most caspases the aspartic acid at position P1 is essential, however caspase 638 3 and 7 can function with a glutamic acid at this position (31). When residue D7 was 639 mutated to glycine (data not shown), alanine or aspartic acid only the D7E mutation 640 allowed virus recovery. It is plausible that D7E is the only mutation that may have 641 maintained a functional caspase cleavage site contributing to the lack of recovery of other 642 viruses. Another plausible explanation is that the D7A and D7G mutations may have 643 27 altered vRNP packaging signals, although it is unlikely that a single nucleotide change 644
would render such signals non-functional. 645
646
Of the mutant BNP constructs created only three led to the production of viable viruses 647 with two mutant viruses containing mutations in the first ten residues of BNP showing 648 significant attenuation. As replication analysis demonstrated that cells infected with any of 649 the four viruses began releasing infectious particles at the same time post infection (9 650 h.p.i. ; Fig 6) , the mutations therefore did not result in a lag in particle production. At this 651 time point the infectious titres of released virus were equivalent to one infectious particle 652 produced from every 10-50 cells infected, likely indicating that virus release had only just 653 begun. At this time post-infection it is likely that wt and mutant viruses had produced 654 enough protein/vRNPs to begin generating and releasing virus particles, therefore one 655 might not expect a large difference in released titres at this time point. However from 12 656 h.p.i. the rBNP-M4 and rBNP-D7E viruses were attenuated by 1.5-2 logs (Fig. 6B) . 657
Despite the predominant nuclear localization of these mutant BNP proteins during 658 infection they demonstrated a reduced ability to support transcription and replication of a 659 luciferase-based mini-replicon (Fig. 7A) likely resulting from significant reductions in 660 mRNA and vRNA/cRNA synthesis over the time frame of a single cycle of replication (Fig.  661   8) . It is plausible that after the initial virus release at 9 h.p.i. the higher levels of 662 transcription and replication of wt virus genome compared to those of the mutant viruses 663 resulted in higher levels of protein and RNA available for virion production. This potentially 664 generated higher levels of infectious wt virus over time, thereby resulting in the observed 665 attenuation of the mutant viruses after 9 h.p.i. (Fig 7A) . Although luciferase levels were reduced in this assay they were not 672 reduced in the transfection-based mini-replicon assay in Fig 1, however in 
